secwatch.observer — SEC 8-K summary
======================================

Issuer:     REVVITY, INC. (RVTY)
CIK:        0000031791
Form:       8-K
Filed at:   2024-01-09T23:59:59+00:00
Accession:  0001157523-24-000035
Event type: earnings
Sentiment:  neutral
Materiality: 0.70
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Revvity issues preliminary Q4 2023 revenue at least $690M with organic decline of 4-7%, EPS guidance reaffirmed
--------------------------------------------------------------------------------

- Q4 2023 revenue expected at least $690M, reported organic revenue decline of approx. 7% and non-COVID organic decline of 4% year-over-year.
- Full-year 2023 adjusted EPS expected to meet or exceed the guidance provided on October 30, 2023.
- Company will release Q4 and full-year 2023 results on February 1, 2024, with a conference call at 8:00 a.m. ET hosted by CEO Prahlad Singh.
- CEO Prahlad Singh presented at the 42nd Annual J.P. Morgan Healthcare Conference on January 9, 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/31791/000115752324000035/0001157523-24-000035-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/31791/000115752324000035/a53878895.htm
  HTML page:      https://secwatch.observer/filing/0001157523-24-000035

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer